ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 164 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $829,852 | -27.9% | 38,544 | -9.7% | 0.00% | -66.7% |
| Q1 2024 | $1,150,338 | -11.8% | 42,700 | -1.9% | 0.01% | -18.2% |
| Q4 2023 | $1,304,894 | +53.0% | 43,540 | -12.6% | 0.01% | +37.5% |
| Q1 2023 | $853,057 | -25.4% | 49,799 | -14.8% | 0.01% | -33.3% |
| Q4 2022 | $1,143,867 | +94.2% | 58,450 | +58.3% | 0.01% | +140.0% |
| Q1 2022 | $589,000 | -33.3% | 36,912 | -4.2% | 0.01% | -28.6% |
| Q4 2021 | $883,000 | +193.4% | 38,518 | +453.8% | 0.01% | +133.3% |
| Q2 2021 | $301,000 | -86.0% | 6,955 | -85.6% | 0.00% | -81.2% |
| Q1 2021 | $2,145,000 | -65.6% | 48,346 | -48.9% | 0.02% | -20.0% |
| Q4 2020 | $6,238,000 | – | 94,640 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |